血栓症治療薬市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00004775
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場紹介
血栓症は、動脈または静脈内の異常な血栓を指す医学用語です。血栓症治療薬は、血液の凝固力を低下させ、その結果、肺塞栓症などの血栓症イベントの可能性を減らすことにより、血栓の予防または治療に使用されます。

市場動向< /strong>
血栓症治療薬市場は、血栓症患者数の増加、製剤製品の入手可能性と機能の改善、高齢者人口の増加、肥満の増加、座りがちなライフスタイルなどの要因により、予測期間中に成長すると予想されます。国民の罹患率と高齢者の死亡率。それにもかかわらず、非ビタミンK口腔凝固剤の高コストとジェネリック医薬品の入手可能性は、予測期間中の市場の成長を制限すると予想されます。

市場範囲
「2031年までの世界の血栓症治療薬市場分析」は、世界の血栓症治療薬市場に特に焦点を当てた製薬業界の専門的かつ詳細な調査です。市場動向分析。このレポートは、機器、タイプ、最終用途、地域ごとに詳細な市場分割を行い、血栓症治療薬市場の概要を提供することを目的としています。世界の血栓症治療薬市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、血栓症治療薬市場の主要プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション
世界の血栓症医薬品市場は、医薬品、適応症、流通チャネルに基づいて分割されています。薬物に基づいて、市場は第Xa因子阻害剤、低分子量ヘパリン、P2Y12血小板阻害剤、その他に分類されます。適応症に基づいて、市場は肺塞栓症、心房細動、深部静脈血栓症、その他に分類されます。流通チャネルに基づいて、市場は病院薬局、小売薬局、オンライン薬局に分類されます。

このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界の血栓症治療薬市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南および南。中米。各地域ごとの血栓症薬市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界18か国の分析と予測、およびこの地域で広まっている現在の傾向と機会をカバーしています。

レポートは、需要側と供給側の両方から血栓症治療薬市場に影響を与える要因を分析し、血栓症治療薬市場に影響を与える市場力学をさらに評価します。予測期間中の市場、つまり推進要因、制約、機会、将来の傾向。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南および南。これらの地域の血栓症治療薬市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後の中央アメリカ。

市場参加者
レポートは、有機的および無機的成長戦略としての血栓症治療薬市場の主要な発展をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、提携および提携でした。コラボレーション。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。血栓症治療薬市場からの市場支払者は、世界市場での血栓症治療薬市場の需要の高まりに伴い、将来的に有利な成長機会が期待されています。以下は、血栓症治療薬市場に従事するいくつかの企業のリストです。

このレポートには、血栓症治療薬市場企業のSWOT分析と市場戦略とともにプロファイルも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、会社概要、提供されているコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を提供しています。
  • GlaxoSmithKline plc
  • バクスター インターナショナル Inc
  • ジョンソン&amp;ジョンソン
  • サノフィ
  • ブリストル・マイヤーズ スクイブ カンパニー
  • アストラゼネカ plc
  • バイエル AG
  • アスペン ファーマケア ホールディングス リミテッド
  • Boehringer Ingelheim GmbH
  • Pfizer, Inc
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、さまざまなカスタマイズ オプションを提供しています。既存の調査。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Thrombosis Drugs Market?

Thrombosis Drugs Market is expected to grow at a CAGR of 9% between 2023-2031

What are the driving factors impacting the Thrombosis Drugs Market?

The driving factors impacting the Thrombosis Drugs Market are: Increasing Prevalence of Cardiovascular Diseases, Aging Population and Growing Incidence of Atherosclerosis

What are the future trends of the Thrombosis Drugs Market?

The future trends of the Thrombosis Drugs Market are: Development of Novel Anticoagulants, Personalized Medicine and Focus on Combination Therapies

Which are the leading players operating in the Thrombosis Drugs Market?

The leading players of the market are: GlaxoSmithKline plc, Baxter International Inc, Johnson & Johnson, Sanofi, Bristol-Myers Squibb Company, AstraZeneca plc, Bayer AG, Aspen Pharmacare Holdings Limited, Boehringer Ingelheim GmbH, Pfizer, Inc

What are the deliverable formats of the Thrombosis Drugs Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- GlaxoSmithKline plc
- Baxter International Inc
- Johnson & Johnson
- Sanofi
- Bristol-Myers Squibb Company
- AstraZeneca plc
- Bayer AG
- Aspen Pharmacare Holdings Limited
- Boehringer Ingelheim GmbH
- Pfizer, Inc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.